By Olivia Oran and Nadia Damouni (Reuters) - Salix Pharmaceuticals Ltd slashed its full-year forecast on Thursday and said inventory for its key drugs piled up, an issue that people familiar with the matter said dissuaded Allergan Inc from acquiring the drugmaker. The two companies were close to inking a deal, but Botox maker Allergan balked after its due diligence raised questions over inventory levels, the people said, requesting anonymity because the negotiations were confidential. Allergan and Salix representatives declined to comment on the talks. ... via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment